Hjem › Blærekreft
Kliniske studier for Blærekreft rekrutterer i USA
142 studier for Blærekreft rekrutterer deltakere på steder over hele USA.
Byer med flest studier
- New York City, NY35 studier
- Nashville, TN31 studier
- Houston, TX31 studier
- Dallas, TX27 studier
- Boston, MA26 studier
- Washington, DC26 studier
- Los Angeles, CA24 studier
- Baltimore, MD24 studier
- St. Louis, MO22 studier
- Philadelphia, PA21 studier
- Seattle, WA21 studier
- Edison, NJ21 studier
- Chicago, IL21 studier
- Durham, NC20 studier
- Columbus, OH19 studier
- Cleveland, OH18 studier
- Atlanta, GA16 studier
- Queens, NY16 studier
- Baldwin Park, CA14 studier
- San Francisco, CA13 studier
- Portland, OR13 studier
- San Antonio, TX13 studier
- Rochester, MN12 studier
- Kansas City, KS12 studier
- Austin, TX12 studier
- Orange, CA12 studier
- Grand Rapids, MI12 studier
- Birmingham, AL11 studier
- San Diego, CA11 studier
- Milwaukee, WI11 studier
- Denver, CO11 studier
- Irvine, CA11 studier
- Detroit, MI11 studier
- New Rochelle, NY11 studier
- Staten Island, NY11 studier
- Minneapolis, MN11 studier
- Oklahoma City, OK11 studier
- Omaha, NE10 studier
- Myrtle Beach, SC10 studier
- Kansas City, MO10 studier
Etter delstat
- Alabama11 studier
- Alaska3 studier
- Arizona20 studier
- Arkansas15 studier
- California54 studier
- Colorado20 studier
- Connecticut9 studier
- Delaware4 studier
- District of Columbia17 studier
- Florida38 studier
- Georgia19 studier
- Idaho6 studier
- Illinois30 studier
- Indiana14 studier
- Iowa12 studier
- Kansas17 studier
- Kentucky7 studier
- Louisiana13 studier
- Maryland36 studier
- Massachusetts31 studier
- Michigan25 studier
- Minnesota24 studier
- Mississippi3 studier
- Missouri27 studier
- Montana7 studier
- Nebraska11 studier
- Nevada5 studier
- New Hampshire3 studier
- New Jersey26 studier
- New Mexico3 studier
- New York41 studier
- North Carolina26 studier
- North Dakota4 studier
- Ohio36 studier
- Oklahoma12 studier
- Oregon14 studier
- Pennsylvania27 studier
- Rhode Island4 studier
- South Carolina16 studier
- South Dakota4 studier
- Tennessee34 studier
- Texas51 studier
- Utah14 studier
- Vermont3 studier
- Virginia24 studier
- Washington25 studier
- West Virginia5 studier
- Wisconsin17 studier
- Wyoming4 studier
Nylig oppdaterte studier
Offisiell studietekst (engelsk)
Evaluation for NCI Surgery Branch Clinical Research Protocols
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT00001823A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06465069KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07232602En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device
RekruttererObservasjonsstudie
Alder 18 til 120 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT04235764Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07000084Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 40 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05334069Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06770582A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06760819Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial
RekruttererFase 4
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06764095A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06833073A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06172478A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT07090499Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06263153Imaging Study of [89Zr]DFO-YS5 for Cancer Detection
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT07664397Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT07061964Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06470282Enfortumab Vedotin and Stereotactic Radiation for Localized Bladder Cancer
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT06394570Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial Cancer
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07667335Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 2 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT00026884Patient-Centered Surgical Prehabilitation
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 18 til 85 · Alle kjønn · Oppdatert 30. sep. 2026 · NCT05715684The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07285044Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07566156Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT03866382DK222 Study at Hopkins
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT07140315Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07421700Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.